Patents by Inventor Jane Shiah

Jane Shiah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extended release biodegradable ocular implants
    Publication number: 20050244467
    Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.
    Type: Application
    Filed: April 30, 2004
    Publication date: November 3, 2005
    Applicant: ALLERGAN, INC.
    Inventors: Thierry Nivaggioli, Jane Shiah, Qing Lin
  • Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
    Publication number: 20050244470
    Abstract: Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants may be placed in an eye to treat or reduce the occurrence of one or more ocular conditions.
    Type: Application
    Filed: April 30, 2004
    Publication date: November 3, 2005
    Applicant: Allergan, Inc.
    Inventors: Patrick Hughes, Thomas Malone, Gerald De Vries, Jeffrey Edelman, Joan-En Chang-Lin, Jane Shiah, Thierry Nivaggioli
  • Biodegradable intravitreal tyrosine kinase implants
    Publication number: 20050244475
    Abstract: Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into the vitreous of an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants can be placed in an eye to treat or reduce the occurrence of one or more ocular conditions, such as posterior ocular conditions.
    Type: Application
    Filed: April 29, 2005
    Publication date: November 3, 2005
    Applicant: ALLERGAN, INC.
    Inventors: Jeffrey Edelman, Patrick Hughes, Thomas Malone, Gerald DeVries, Joan-En Chang-Lin, Jane Shiah, Thierry Nivaggioli, Lon Spada, Wendy Blanda